Image not available in RecallScope.
AvKARE Valsartan and Hydrochlorothiazide 80 mg 12.5 mg tablets, 90-count bottle, Rx Only
Official notice
12 Sept 2018
An official FDA notice concerns AvKARE Valsartan and Hydrochlorothiazide 80 mg 12.5 mg tablets, 90-count bottle, Rx Only. CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Published 2018-09-12.
What to do now
This recall has been terminated. See the official FDA notice for the latest status.
Units affected
12,240
Recall number
D-1173-2018
Official notice
2018-09-12
The hazard
The hazard
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
How to check if you’re affected
How to check if you’re affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Event Ids
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Units affected
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Avkare. Contact: Avkare Incorporated.
Source & status
Source & status
Recall details
Recall details
Recall number
Event ID
Units affected
Status
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week’s recalls before you need them.
One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.